Concepedia

Joseph W. Kim

JW

41

Publications

3.2K

Citations

25

H-Index

2001

Active since

Affiliations

Yale Cancer Center(Current)

Yale University

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

National Cancer Institute

Joseph W. Kim is an author at Yale Cancer Center specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2001–2024

41

Publications

41

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial

Padmanee Sharma, Margaret K. Callahan, Petri Bono et al. · The Lancet Oncology · 2016 · 676 citations · Full text

, , +7

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer

Yelena Y. Janjigian, Johanna C. Bendell, Emiliano Calvo et al. · Journal of Clinical Oncology · 2018 · 613 citations · Full text

Transferable anticancer innate immunity in spontaneous regression/complete resistance mice

Amy M. Hicks, Gregory Riedlinger, Mark C. Willingham et al. · Proceedings of the National Academy of Sciences · 2006 · 164 citations · Full text

, , +14

First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors

Julius Strauss, Christopher R. Heery, Joseph W. Kim et al. · Clinical Cancer Research · 2018 · 164 citations · Full text

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

Andrea B. Apolo, Karla V. Ballman, Guru Sonpavde et al. · New England Journal of Medicine · 2024 · 125 citations · Full text

Rows per page

1–5 of 41